mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.008 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.13 |
0.009 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |